Thibault De La Motte Rouge
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 101 publications
Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 15, 2026
Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 23, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].
Journal: Bulletin du cancer
Published: April 12, 2026
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.
Journal: Lancet (London, England)
Published: February 04, 2026
Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer.
Journal: Therapeutic advances in medical oncology
Published: January 27, 2026
Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).
Journal: Bulletin du cancer
Published: January 19, 2026
Advanced high-grade serous ovarian cancer treated with intensive cytoreductive surgery and chemotherapy: prognostic impact of lymph node involvement: analysis of the French national ESME-Unicancer database.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: November 13, 2025
French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer
Journal: Bulletin du cancer
Published: October 23, 2025
BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: August 20, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 25, 2025
Last Updated: 09/26/2026